×
Amazon, Google, and Microsoft warn employees to rush back to the US

Amazon, Google, and Microsoft warn employees to rush back to the US

IMPORTANT ADVISORY: New travel restriction for H-1B visa holders

Hi all–We have now reviewed the actual text of today’s Presidential Proclamation on H-1B visas, which you can find here: Restriction on Entry of Certain Nonimmigrant Workers – The White House.

Here’s what you need to know:

First, the proclamation is structured as a travel restriction. Beginning at 12:01 am eastern time on September 21, 2025 (so, 9:01 pm Pacific time tomorrow), individuals will not be able to enter/return to the U.S. in H-1B status unless their petition has an additional $100,000 payment associated with it.

What you need to do:

I will be updating this post later this evening with a form for people to fill out if they are currently outside the U.S. with an H-1B visa. We want to be able to follow up with each individual and provide support and guidance as they try to return within the next 28 hours.

The proclamation does not impact any other visa statuses.

There is other content about the pause in processing H-1B petitions for individuals who are outside the U.S. At this time, we do not interpret this to immediately impact extensions of H-1B status or changes of status to H-1B as long as you are currently in the U.S. We’ll share more about that later.

Source link
#Amazon #Google #Microsoft #warn #employees #rush

Samsung has unveiled a new flexible display technology for foldable phones that’s designed to be slimmer, more durable, and less prone to creasing. The Flex Titanium tech is the culmination of everything that the company has learned over seven generations of foldables, according to Samsung, and will debut with the upcoming Galaxy Z Fold 8 and Galaxy Z Fold 8 Ultra. And since Samsung Display is a long-time Apple supplier, this improved display might even appear in the rumored iPhone foldable expected later this year.

As its name suggests, the Flex Titanium display uses a combination of two titanium-based components to improve strength, flexibility, and slimness. A titanium-alloy film provides structural support from underneath the OLED panel, providing “20 times greater mechanical stiffness” compared to polymer film, and measures about one-third the thickness of an average human hair.

A titanium plate located under the film enables tighter bonding with the display module, improving stability when unfolded while “retaining the flexibility needed to accommodate repeated folding,” according to Samsung. This new display tech will also consume less power and produce “ultra-vivid” display visual resolution.

“Together, these advancements enable a strong foldable display that maximizes content immersion on a seamless screen and reduces crease visibility — all while keeping it slim,” Samsung said in its announcement. “By balancing strength, flexibility and structural stability, Samsung continues to set the bar for foldable displays.”

Further details about the display will be available at Samsung’s Galaxy Unpacked event on July 22nd where Samsung’s latest foldables are expected to be showcased.

#Samsungs #foldable #display #harder #crease #damageFoldable Phones,Mobile,News,Samsung,Tech">Samsung’s new foldable display is harder to crease and damageSamsung has unveiled a new flexible display technology for foldable phones that’s designed to be slimmer, more durable, and less prone to creasing. The Flex Titanium tech is the culmination of everything that the company has learned over seven generations of foldables, according to Samsung, and will debut with the upcoming Galaxy Z Fold 8 and Galaxy Z Fold 8 Ultra. And since Samsung Display is a long-time Apple supplier, this improved display might even appear in the rumored iPhone foldable expected later this year.As its name suggests, the Flex Titanium display uses a combination of two titanium-based components to improve strength, flexibility, and slimness. A titanium-alloy film provides structural support from underneath the OLED panel, providing “20 times greater mechanical stiffness” compared to polymer film, and measures about one-third the thickness of an average human hair.A titanium plate located under the film enables tighter bonding with the display module, improving stability when unfolded while “retaining the flexibility needed to accommodate repeated folding,” according to Samsung. This new display tech will also consume less power and produce “ultra-vivid” display visual resolution.“Together, these advancements enable a strong foldable display that maximizes content immersion on a seamless screen and reduces crease visibility — all while keeping it slim,” Samsung said in its announcement. “By balancing strength, flexibility and structural stability, Samsung continues to set the bar for foldable displays.”Further details about the display will be available at Samsung’s Galaxy Unpacked event on July 22nd where Samsung’s latest foldables are expected to be showcased.#Samsungs #foldable #display #harder #crease #damageFoldable Phones,Mobile,News,Samsung,Tech

Flex Titanium tech is the culmination of everything that the company has learned over seven generations of foldables, according to Samsung, and will debut with the upcoming Galaxy Z Fold 8 and Galaxy Z Fold 8 Ultra. And since Samsung Display is a long-time Apple supplier, this improved display might even appear in the rumored iPhone foldable expected later this year.

As its name suggests, the Flex Titanium display uses a combination of two titanium-based components to improve strength, flexibility, and slimness. A titanium-alloy film provides structural support from underneath the OLED panel, providing “20 times greater mechanical stiffness” compared to polymer film, and measures about one-third the thickness of an average human hair.

A titanium plate located under the film enables tighter bonding with the display module, improving stability when unfolded while “retaining the flexibility needed to accommodate repeated folding,” according to Samsung. This new display tech will also consume less power and produce “ultra-vivid” display visual resolution.

“Together, these advancements enable a strong foldable display that maximizes content immersion on a seamless screen and reduces crease visibility — all while keeping it slim,” Samsung said in its announcement. “By balancing strength, flexibility and structural stability, Samsung continues to set the bar for foldable displays.”

Further details about the display will be available at Samsung’s Galaxy Unpacked event on July 22nd where Samsung’s latest foldables are expected to be showcased.

#Samsungs #foldable #display #harder #crease #damageFoldable Phones,Mobile,News,Samsung,Tech">Samsung’s new foldable display is harder to crease and damage

Samsung has unveiled a new flexible display technology for foldable phones that’s designed to be slimmer, more durable, and less prone to creasing. The Flex Titanium tech is the culmination of everything that the company has learned over seven generations of foldables, according to Samsung, and will debut with the upcoming Galaxy Z Fold 8 and Galaxy Z Fold 8 Ultra. And since Samsung Display is a long-time Apple supplier, this improved display might even appear in the rumored iPhone foldable expected later this year.

As its name suggests, the Flex Titanium display uses a combination of two titanium-based components to improve strength, flexibility, and slimness. A titanium-alloy film provides structural support from underneath the OLED panel, providing “20 times greater mechanical stiffness” compared to polymer film, and measures about one-third the thickness of an average human hair.

A titanium plate located under the film enables tighter bonding with the display module, improving stability when unfolded while “retaining the flexibility needed to accommodate repeated folding,” according to Samsung. This new display tech will also consume less power and produce “ultra-vivid” display visual resolution.

“Together, these advancements enable a strong foldable display that maximizes content immersion on a seamless screen and reduces crease visibility — all while keeping it slim,” Samsung said in its announcement. “By balancing strength, flexibility and structural stability, Samsung continues to set the bar for foldable displays.”

Further details about the display will be available at Samsung’s Galaxy Unpacked event on July 22nd where Samsung’s latest foldables are expected to be showcased.

#Samsungs #foldable #display #harder #crease #damageFoldable Phones,Mobile,News,Samsung,Tech
Miles Wang, an OpenAI researcher whose work includes using AI to accelerate scientific and biological discovery, is leaving the ChatGPT maker to launch a new startup focused on developing AI models for drug discovery, according to four people with knowledge of his plans. Several other OpenAI researchers are expected to join the new company.  

Wang is in talks to raise about $200 million at a $2 billion valuation, two of the people said. Lightspeed is in discussions to lead the funding round, according to sources. Talks are ongoing, the deal may not be final and details could change.

Wang disputed the story’s funding figures and description of the company but did not specify the correct numbers or details. Lightspeed didn’t respond to a request for comment.

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences. Chai Discovery, a two-year-old startup developing AI models that can predict molecular interactions to identify new drugs, announced on Tuesday that it raised $400 million at a $3.8 billion valuation. (Co-founder Josh Meier also passed through OpenAI as a researcher.) Meanwhile, Google DeepMind spinout Isomorphic Labs, which also develops AI models for drug discovery, raised a $2.1 billion Series B in May.

Wang’s new startup may be working on AI models that will help find new uses for existing drugs and possibly those that previously failed in trials, a couple of sources told TechCrunch. Finding new uses for FDA-approved drugs can result in significantly faster time to revenue than developing new drugs from scratch, as these medicines have already been tested for safety.

Wang joined OpenAI in 2024 after dropping out from Harvard, where he was working on a bachelor’s degree in computer science. (In recent years, investors are once again comfortable betting on young founders who haven’t completed college.)

At OpenAI, he co-authored research papers, including evaluating how AI models can automate and accelerate scientific discovery.

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

#OpenAI #researcher #Miles #Wang #talks #launch #drug #discovery #startup #valued #TechCrunchdrug discovery,lightspeed,OpenAI">OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at B | TechCrunch
Miles Wang, an OpenAI researcher whose work includes using AI to accelerate scientific and biological discovery, is leaving the ChatGPT maker to launch a new startup focused on developing AI models for drug discovery, according to four people with knowledge of his plans. Several other OpenAI researchers are expected to join the new company.  

Wang is in talks to raise about 0 million at a  billion valuation, two of the people said. Lightspeed is in discussions to lead the funding round, according to sources. Talks are ongoing, the deal may not be final and details could change.







Wang disputed the story’s funding figures and description of the company but did not specify the correct numbers or details. Lightspeed didn’t respond to a request for comment.

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences. Chai Discovery, a two-year-old startup developing AI models that can predict molecular interactions to identify new drugs, announced on Tuesday that it raised 0 million at a .8 billion valuation. (Co-founder Josh Meier also passed through OpenAI as a researcher.) Meanwhile, Google DeepMind spinout Isomorphic Labs, which also develops AI models for drug discovery, raised a .1 billion Series B in May.

Wang’s new startup may be working on AI models that will help find new uses for existing drugs and possibly those that previously failed in trials, a couple of sources told TechCrunch. Finding new uses for FDA-approved drugs can result in significantly faster time to revenue than developing new drugs from scratch, as these medicines have already been tested for safety.

Wang joined OpenAI in 2024 after dropping out from Harvard, where he was working on a bachelor’s degree in computer science. (In recent years, investors are once again comfortable betting on young founders who haven’t completed college.)

At OpenAI, he co-authored research papers, including evaluating how AI models can automate and accelerate scientific discovery.

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.#OpenAI #researcher #Miles #Wang #talks #launch #drug #discovery #startup #valued #TechCrunchdrug discovery,lightspeed,OpenAI

Miles Wang, an OpenAI researcher whose work includes using AI to accelerate scientific and biological discovery, is leaving the ChatGPT maker to launch a new startup focused on developing AI models for drug discovery, according to four people with knowledge of his plans. Several other OpenAI researchers are expected to join the new company.  

Wang is in talks to raise about $200 million at a $2 billion valuation, two of the people said. Lightspeed is in discussions to lead the funding round, according to sources. Talks are ongoing, the deal may not be final and details could change.

Wang disputed the story’s funding figures and description of the company but did not specify the correct numbers or details. Lightspeed didn’t respond to a request for comment.

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences. Chai Discovery, a two-year-old startup developing AI models that can predict molecular interactions to identify new drugs, announced on Tuesday that it raised $400 million at a $3.8 billion valuation. (Co-founder Josh Meier also passed through OpenAI as a researcher.) Meanwhile, Google DeepMind spinout Isomorphic Labs, which also develops AI models for drug discovery, raised a $2.1 billion Series B in May.

Wang’s new startup may be working on AI models that will help find new uses for existing drugs and possibly those that previously failed in trials, a couple of sources told TechCrunch. Finding new uses for FDA-approved drugs can result in significantly faster time to revenue than developing new drugs from scratch, as these medicines have already been tested for safety.

Wang joined OpenAI in 2024 after dropping out from Harvard, where he was working on a bachelor’s degree in computer science. (In recent years, investors are once again comfortable betting on young founders who haven’t completed college.)

At OpenAI, he co-authored research papers, including evaluating how AI models can automate and accelerate scientific discovery.

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

#OpenAI #researcher #Miles #Wang #talks #launch #drug #discovery #startup #valued #TechCrunchdrug discovery,lightspeed,OpenAI">OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B | TechCrunch

Miles Wang, an OpenAI researcher whose work includes using AI to accelerate scientific and biological discovery, is leaving the ChatGPT maker to launch a new startup focused on developing AI models for drug discovery, according to four people with knowledge of his plans. Several other OpenAI researchers are expected to join the new company.  

Wang is in talks to raise about $200 million at a $2 billion valuation, two of the people said. Lightspeed is in discussions to lead the funding round, according to sources. Talks are ongoing, the deal may not be final and details could change.

Wang disputed the story’s funding figures and description of the company but did not specify the correct numbers or details. Lightspeed didn’t respond to a request for comment.

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences. Chai Discovery, a two-year-old startup developing AI models that can predict molecular interactions to identify new drugs, announced on Tuesday that it raised $400 million at a $3.8 billion valuation. (Co-founder Josh Meier also passed through OpenAI as a researcher.) Meanwhile, Google DeepMind spinout Isomorphic Labs, which also develops AI models for drug discovery, raised a $2.1 billion Series B in May.

Wang’s new startup may be working on AI models that will help find new uses for existing drugs and possibly those that previously failed in trials, a couple of sources told TechCrunch. Finding new uses for FDA-approved drugs can result in significantly faster time to revenue than developing new drugs from scratch, as these medicines have already been tested for safety.

Wang joined OpenAI in 2024 after dropping out from Harvard, where he was working on a bachelor’s degree in computer science. (In recent years, investors are once again comfortable betting on young founders who haven’t completed college.)

At OpenAI, he co-authored research papers, including evaluating how AI models can automate and accelerate scientific discovery.

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

#OpenAI #researcher #Miles #Wang #talks #launch #drug #discovery #startup #valued #TechCrunchdrug discovery,lightspeed,OpenAI

Post Comment